Modeling drug efficacy in cancer
Krzysztof Koras(University of Warsaw), Ewa Szczurek(Helmholtz Zentrum München), Błażej Miasojedow(University of Warsaw), Dilafruz Juraeva(Merck KGaA, Darmstadt (Germany)), Anna Gambin(University of Warsaw), Johanna Mazur(Institute for Medical Informatics and Biostatistics), Eike Staub(Merck KGaA, Darmstadt (Germany))
Research in Computational Molecular Biology
April 21, 2018
Cited by 0
Related Papers
Eleven grand challenges in single-cell data science
|Genome biology|2020|1.5k
Tepotinib in Non–Small-Cell Lung Cancer with <i>MET</i> Exon 14 Skipping Mutations
|New England Journal of Medicine|2020|879
Cell competition is a tumour suppressor mechanism in the thymus
|Nature|2014|242
Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma
|Cell Death and Disease|2013|235
Discovering highly potent antimicrobial peptides with deep generative model HydrAMP
|Nature Communications|2023|193